These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

170 related articles for article (PubMed ID: 31668689)

  • 1. Introduction to the special issue on innovative interventions and approaches to expand medication assisted treatment: Seizing research opportunities made available by the opioid STR program.
    Watson DP; Andraka-Christou B; Clarke T; Wiegandt J
    J Subst Abuse Treat; 2020 Jan; 108():1-3. PubMed ID: 31668689
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Implementation and evaluation of Missouri's Medication First treatment approach for opioid use disorder in publicly-funded substance use treatment programs.
    Winograd RP; Wood CA; Stringfellow EJ; Presnall N; Duello A; Horn P; Rudder T
    J Subst Abuse Treat; 2020 Jan; 108():55-64. PubMed ID: 31277891
    [TBL] [Abstract][Full Text] [Related]  

  • 3. State targeted response to the opioid Crisis grants (opioid STR) program: Preliminary findings from two case studies and the national cross-site evaluation.
    High PM; Marks K; Robbins V; Winograd R; Manocchio T; Clarke T; Wood C; Stringer M
    J Subst Abuse Treat; 2020 Jan; 108():48-54. PubMed ID: 31303359
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Medication-Assisted Treatment (MAT) for Opioid Addiction: Introduction to the Special Issue.
    McElrath K; Joseph H
    Subst Use Misuse; 2018 Jan; 53(2):177-180. PubMed ID: 29220615
    [TBL] [Abstract][Full Text] [Related]  

  • 5. The Washington State Hub and Spoke Model to increase access to medication treatment for opioid use disorders.
    Reif S; Brolin MF; Stewart MT; Fuchs TJ; Speaker E; Mazel SB
    J Subst Abuse Treat; 2020 Jan; 108():33-39. PubMed ID: 31358328
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Implementation of the hub and spoke model for opioid use disorders in California: Rationale, design and anticipated impact.
    Miele GM; Caton L; Freese TE; McGovern M; Darfler K; Antonini VP; Perez M; Rawson R
    J Subst Abuse Treat; 2020 Jan; 108():20-25. PubMed ID: 31399272
    [TBL] [Abstract][Full Text] [Related]  

  • 7. A community outreach intervention to link individuals with opioid use disorders to medication-assisted treatment.
    Scott CK; Dennis ML; Grella CE; Kurz R; Sumpter J; Nicholson L; Funk RR
    J Subst Abuse Treat; 2020 Jan; 108():75-81. PubMed ID: 31399271
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Medication-assisted therapy for opioid-dependent incarcerated populations in New Mexico: statewide efforts to increase access.
    Trigg BG; Dickman SL
    Subst Abus; 2012; 33(1):76-84. PubMed ID: 22263716
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Medication-Assisted Treatment for Opioid Addiction in the United States: Critique and Commentary.
    McElrath K
    Subst Use Misuse; 2018 Jan; 53(2):334-343. PubMed ID: 28862903
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Replication of an emergency department-based recovery coaching intervention and pilot testing of pragmatic trial protocols within the context of Indiana's Opioid State Targeted Response plan.
    Watson DP; Brucker K; McGuire A; Snow-Hill NL; Xu H; Cohen A; Campbell M; Robison L; Sightes E; Buhner R; O'Donnell D; Kline JA
    J Subst Abuse Treat; 2020 Jan; 108():88-94. PubMed ID: 31200985
    [TBL] [Abstract][Full Text] [Related]  

  • 11. The case for a medication first approach to the treatment of opioid use disorder.
    Winograd RP; Presnall N; Stringfellow E; Wood C; Horn P; Duello A; Green L; Rudder T
    Am J Drug Alcohol Abuse; 2019; 45(4):333-340. PubMed ID: 31084515
    [No Abstract]   [Full Text] [Related]  

  • 12. Access to treatment for opioid use disorders: Medical student preparation.
    McCance-Katz EF; George P; Scott NA; Dollase R; Tunkel AR; McDonald J
    Am J Addict; 2017 Jun; 26(4):316-318. PubMed ID: 28394437
    [TBL] [Abstract][Full Text] [Related]  

  • 13. 21
    Beletsky L
    Am J Law Med; 2018 May; 44(2-3):359-385. PubMed ID: 30106650
    [No Abstract]   [Full Text] [Related]  

  • 14. Assessing the needs of front-line providers in addressing the opioid crisis in South Carolina.
    Moreland A; McCauley J; Barth K; Bogdon C; Killeen T; Haynes L; Jennings L; Guille C; Goldsby S; Brady K
    J Subst Abuse Treat; 2020 Jan; 108():4-8. PubMed ID: 31303360
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Expanding access to buprenorphine treatment in rural areas with the use of telemedicine.
    Weintraub E; Greenblatt AD; Chang J; Himelhoch S; Welsh C
    Am J Addict; 2018 Dec; 27(8):612-617. PubMed ID: 30265425
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Removing One Barrier to Opioid Use Disorder Treatment: Is It Enough?
    Weimer MB; Wakeman SE; Saitz R
    JAMA; 2021 Mar; 325(12):1147-1148. PubMed ID: 33630020
    [No Abstract]   [Full Text] [Related]  

  • 17. Deploying science to change hearts and minds: Responding to the opioid crisis.
    Walsh SL; Long KQX
    Prev Med; 2019 Nov; 128():105780. PubMed ID: 31319116
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Demystifying buprenorphine misuse: Has fear of diversion gotten in the way of addressing the opioid crisis?
    Doernberg M; Krawczyk N; Agus D; Fingerhood M
    Subst Abus; 2019; 40(2):148-153. PubMed ID: 31008694
    [TBL] [Abstract][Full Text] [Related]  

  • 19. The Comprehensive Addiction and Recovery Act: Opioid Use Disorder and Midwifery Practice.
    Murphy J; Goodman D; Johnson MC; Terplan M
    Obstet Gynecol; 2018 Mar; 131(3):542-544. PubMed ID: 29420414
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Projected Contributions of Nurse Practitioners and Physicians Assistant to Buprenorphine Treatment Services for Opioid Use Disorder in Rural Areas.
    Andrilla CHA; Patterson DG; Moore TE; Coulthard C; Larson EH
    Med Care Res Rev; 2020 Apr; 77(2):208-216. PubMed ID: 30089426
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 9.